New Reforms to Prescription Drug Pricing in the US: Opportunities and Challenges

Thomas J Hwang^{1

2}, Aaron S Kesselheim¹, Benjamin N Rome¹

Affiliations

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Thomas J Hwang et al. JAMA. 2022.

. 2022 Sep 20;328(11):1041-1042.

doi: 10.1001/jama.2022.15268.

Thomas J Hwang^{1

2}, Aaron S Kesselheim¹, Benjamin N Rome¹

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

No abstract available

MeSH terms